Page last updated: 2024-11-05

magnesium phosphate (2:3)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Magnesium phosphate (2:3) is a compound with the chemical formula Mg3(PO4)2. It exists in several different forms, each with its own unique properties and applications. One common form is the hexahydrate, Mg3(PO4)2·6H2O, which is a white, crystalline solid. This form is often found in nature as the mineral bobierrite. Magnesium phosphate can be synthesized by reacting magnesium salts with phosphate salts in aqueous solution. For example, magnesium chloride and sodium phosphate can be reacted to form magnesium phosphate and sodium chloride. Magnesium phosphate is an important compound in various fields, including agriculture, medicine, and industry. In agriculture, it is used as a fertilizer to provide magnesium and phosphorus to plants. In medicine, it is used as an antacid to neutralize stomach acid. It can also be used as a phosphate binder in patients with kidney disease. The importance of magnesium phosphate is evident in its widespread applications, its role in biological systems, and its potential for further technological development. Its unique properties, including its high solubility and bioavailability, make it a valuable compound for various applications. Magnesium phosphate is studied extensively for its potential applications in areas such as drug delivery, biomaterials, and nanotechnology. It is particularly interesting for its ability to interact with biological systems and form stable, biocompatible materials.'

Cross-References

ID SourceID
PubMed CID24439
CHEMBL ID2106873
CHEBI ID190298
MeSH IDM0319021

Synonyms (31)

Synonym
phosphoric acid, magnesium salt (2:3)
magnesium phosphate
trimagnesium diphosphate
trimagnesium phosphate
CHEBI:190298
7757-87-1
magnesium phosphate anhydrous
magnesium orthophosphate
magnesium phosphate, tribasic, anhydrous
trimagnesium diorthophosphate
magnesium phosphate (3:2)
tertiary magnesium phosphate
tribasic magnesium phosphate
xmk14etw2d ,
trimagnesium bis(orthophosphate)
magnesium phosphate, neutral
magnesium phosphate (mg3(po4)2)
CHEMBL2106873
AKOS015902400
GVALZJMUIHGIMD-UHFFFAOYSA-H
magnesium phosphate, tribasic [mi]
magnesium phosphate anhydrous [hsdb]
trimagnesium phosphate [inci]
magnesium phosphate [who-dd]
magnesium phosphate, tribasic [fcc]
magnesiumphosphate
DTXSID00872527
DB13862
magnesium orthophosphate(v)
Q6731399
trimagnesium;diphosphate

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Although no absolute value of the oral bioavailability of trimagnesium dicitrate could be determined from the data, our results may be important in helping to elucidate the influence of magnesium preparations on the plasma magnesium concentration."( Increase in magnesium plasma level after orally administered trimagnesium dicitrate.
Latz, R; Mutschler, E; Nyulassy, S; Trnovec, T; Vierling, W; Wilimzig, C, 1996
)
0.29

Dosage Studied

ExcerptRelevanceReference
"Presentation of one case of ammonium-magnesium phosphate calculi breakdown using systemic medical treatment with oral Acetohydroxamine acid dosed at 125 mg/8 h and antibiotic therapy based on the antibiogram results."( [Dissolution of ammonium-magnesium phosphate lithiasis with medical systemic treatment. Report of a case].
Alfonso Sánchez, M; Fradejas Rodríguez, A; Hidalgo Peñin, F; Lago Montero, A; Porto Sierra, M; Tarroc Blanco, A; Tinajas Saldaña, A, 1999
)
0.3
" Potential benefits include recovery of phosphate for reuse, lower required dosage of calcium for fluoride removal, and less amount of CaF(2) sludge."( Selective separation of phosphate and fluoride from semiconductor wastewater.
Liu, JC; Warmadewanthi, B, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
inorganic magnesium salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (212)

TimeframeStudies, This Drug (%)All Drugs %
pre-199035 (16.51)18.7374
1990's14 (6.60)18.2507
2000's33 (15.57)29.6817
2010's83 (39.15)24.3611
2020's47 (22.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.56 (24.57)
Research Supply Index5.40 (2.92)
Research Growth Index4.96 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.92%)5.53%
Reviews8 (3.67%)6.00%
Case Studies11 (5.05%)4.05%
Observational0 (0.00%)0.25%
Other197 (90.37%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]